Everyone’s talking about ivermectin, a veterinary antiparasitic drug that is touted to be effective in treating COVID-19. What do the latest studies and data say about the efficacy of ivermectin in preventing or treating COVID-19? Why is it important for sound clinical trials to be carried out before the drug is approved for general use? Consultant urologist Dr George Lee is joined by Emeritus Prof PT Thomas, Executive Dean, Faculty of Health and Medical Sciences, Taylor’s University to find out more.

Image source: Shutterstock 

Produced by: Lim Sue Ann

Presented by: Meera Sivasothy

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Business Analysis,  Trends and Forecasts,  Markets,  Personal Development,  Politics,  Social Issues,  law & legal matters,  Personal Finance,  Investments,  Financial Literacy,  Young Finance,  Entrpreneurship,  Environment,  Science,  Health Policy,  Diseases & Conditions,  Mental Health,  Healthy Living,  Fitness,  Medical Innovation and Technology

Tags:  The Bigger Picture,  Health & Living,  COVID-19,  ivermectin,  hydroxychloroquine,  drugs,